Holocene Advisors, LP Pulmonx Corp Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$10.78 - $13.65 $1 Million - $1.27 Million	93,153 New	93,153 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $186,522 - $372,377	-13,323 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $608,649 - $1.03 Million	-28,805 Reduced 68.37%	13,323 $331,000
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $357,174 - $542,011	-12,018 Reduced 22.2%	42,128 $1.35 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $1.13 Million - $1.4 Million	31,409 Added 138.14%	54,146 $1.95 Million

Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $855,138 - $1.09 Million	22,737 New	22,737 $1 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.